Highlights•Myasthenia gravis is an antibody-mediated disease.•Antibodies in myasthenia
gravis are directed against several postsynaptic neuromuscular proteins and …

The most common form of Myasthenia gravis (MG) is due to anti-acetylcholine receptor
(AChR) antibodies and is frequently associated with thymic pathology. In this review, we …

Myasthenia gravis (MG) is a prototypical B cell-mediated autoimmune disease affecting 20–
50 people per 100,000. The majority of patients fall into two clinically distinguishable types …

Myasthenia gravis is a disorder of neuromuscular transmission that leads to fatigue of
skeletal muscles and fluctuating weakness. Myasthenia that affects children can be …

Myasthenia gravis: new developments in research and treatmen... : Current Opinion in
Neurology Myasthenia gravis: new developments in research and treatment : Current …

Background and purpose Myasthenia gravis (MG) is an autoimmune disease caused by
antibody mediated impairment in the neuromuscular junction. Seronegative MG (SNMG) …

In autoimmune myasthenia gravis (MG), the identification of antibodies and characterization
of serological subgroups is of great importance for diagnosis and management of the …

Background Myasthenia gravis (MG) with antibodies to the muscle-specific kinase (MuSK)
has a characteristic phenotype. Ocular manifestations have not been systematically …

Introduction We assessed antibodies against low‐density lipoprotein receptor‐related
protein 4 (LRP4‐Ab) in a Chinese population with myasthenia gravis (MG). Methods Serum …

Since the first report of experimental animal models of myasthenia gravis (MG) with
autoantibodies against low-density lipoprotein receptor-related protein 4 (LRP4), there have …